Related Experiment Videos
Granulocyte transfusion therapy: experimental basis and clinical applications
The Journal of the American Osteopathic Association
|April 1, 1977
Summary
Granulocyte replacement therapy can improve outcomes for infected patients with severe neutropenia. However, optimal procurement, administration, and compatibility methods require further research.
Area of Science:
- Hematology
- Infectious Diseases
- Transfusion Medicine
Background:
- Severe neutropenia increases infection risk and mortality.
- Granulocyte replacement therapy is a potential treatment option.
Purpose of the Study:
- To evaluate the effectiveness of granulocyte replacement therapy.
- To identify optimal methods for granulocyte procurement and administration.
- To assess compatibility prediction methods.
Main Methods:
- Review of existing literature on granulocyte therapy.
- Analysis of patient outcomes with severe neutropenia and infection.
- Discussion of current transfusion practices and challenges.
Main Results:
- Granulocyte replacement therapy shows effectiveness in improving short-term and possibly long-term prognosis.
- Methods for granulocyte procurement and administration are still under investigation.
- No reliable method for predicting compatibility has been developed.
Conclusions:
- Granulocyte transfusion therapy is indicated for severely neutropenic patients with documented infections, as an adjunct to antibiotics.
- This therapy should be administered only at specialized institutions.
- Further research is needed to optimize granulocyte therapy protocols.